ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2020
Assessing disability and relapses in multiple sclerosis on tele-neurology.
Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07664865 (Digitalization of Procedures for Neuropsychological Assessment for Neurocognitive Disorders), which is not on this map. Cited by 47 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Digitalization of Procedures for Neuropsychological Assessment for Neurocognitive Disorders: Standardization and Clinical Validation of the Teleneuropsychology Platform Tenèpsia®
Who cites it
47 citing papers in PubMed.
- Comparison of different telerehabilitation protocols for urogenital symptoms in females with multiple sclerosis: a randomized controlled trial.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024Trial
- A digital health home intervention for people within the Alzheimer's disease continuum: results from the Ability-TelerehABILITation pilot randomized controlled trial.Annals of medicine · 2023Trial
- Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi-center study.Headache · 2022Trial
- Nurse-Led Digital Interventions for Patients with Multiple Sclerosis: A Scoping Review.Medical sciences (Basel, Switzerland) · 2026Article
- In vivo CRISPR screen reveals regulation of macrophage states in neuroinflammation.Nature neuroscience · 2026Article
- Rehabilitation technology in assessment and treatment of arm and hand function in myotonic dystrophy type 1: A single subject experimental design study.Journal of neuromuscular diseases · 2026Article
- 30-Second Chair Stand and 5-Times Sit-to-Stand Tests Are Interesting Tools for Assessing Disability and Ability to Ambulate among Patients with Multiple Sclerosis.Life (Basel, Switzerland) · 2024Article
- An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis.Cerebellum (London, England) · 2023Review
- Patient satisfaction with televisit in chronic neurologic disorders during Covid-19 pandemic.Acta neurologica Belgica · 2023Article
- Telehealth for amyotrophic lateral sclerosis in a multidisciplinary service in a Brazilian reference center.Arquivos de neuro-psiquiatria · 2023Article
- Feasibility, Usability, and Customer Satisfaction of the Tele-COVID19 Project, Sicilian Model.Medicina (Kaunas, Lithuania) · 2022Article
- Videoconference-Based Physical Performance Tests: Reliability and Feasibility Study.International journal of environmental research and public health · 2022Article
- Practical guidance for telemedicine use in neuro-oncology.Neuro-oncology practice · 2022Review
- Innovating Care in Multiple Sclerosis: Feasibility of Synchronous Internet-Based Teleconsultation for Longitudinal Clinical Monitoring.Journal of personalized medicine · 2022Article
- Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19.Acta neurologica Belgica · 2022Review
- Impact of COVID-19 in Immunosuppressed Children With Neuroimmunologic Disorders.Neurology(R) neuroimmunology & neuroinflammation · 2022Article
- Providers' Shift to Telerehabilitation at the U.S. Veterans Health Administration During COVID-19: Practical Applications.Frontiers in public health · 2022Article
- Rapid introduction of virtual consultation in a hospital-based Consultant-led Antenatal Clinic to minimise exposure of pregnant women to COVID-19.BMJ open quality · 2022Article
- Stress research during the COVID-19 pandemic and beyond.Neuroscience and biobehavioral reviews · 2021Review
- Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAs a consequence of the coronavirus disease 2019 (COVID-19) pandemic, a large amount of consultations will be delivered through tele-medicine, especially for diseases causing chronic disability and requiring immunomodulatory treatments, such as multiple sclerosis (MS).
methodsWe have hereby reviewed available tools for tele-neurology examination in MS, including components of neurological examination that can be assessed through video, patient-reported outcome measures (PROMs), and digital technology.
resultsOverall, we have suggested a battery for assessing MS disability and relapses on tele-medicine, which brings together conventional examination, PROMs (e.g., Patient Determined Disease Steps, MS Impact Scale), and cognitive tests (Symbol Digit Modalities Test) that can be delivered remotely and in multiple languages. DISCUSSION: The use of common tools for neurological examination could improve tele-neurology practice for both general neurologists and MS specialists, and quality of care for people with MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.